Who is at risk of low blood sugar on tirzepatide, and what are the warning signs?

Patients taking tirzepatide with insulin or sulfonylureas are at the highest risk of low blood sugar. Warning signs include shakiness, sweating, and confusion.

How Tirzepatide Affects Blood Sugar

Tirzepatide is a dual GIP and GLP-1 receptor agonist that helps control blood sugar in patients with type 2 diabetes. It works by stimulating insulin secretion from the pancreas only when blood glucose levels are elevated. This is known as a glucose-dependent mechanism.

Because its action is tied to blood sugar levels, tirzepatide used by itself (as monotherapy) has a low risk of causing hypoglycemia (low blood sugar). The body's natural safeguards are less likely to be overridden compared to medications that lower glucose regardless of current levels.

Clinical trials support this low risk profile for monotherapy. The key risk arises when tirzepatide is combined with other medications specifically designed to lower blood sugar, which can create a potent, compounding effect.

Who Is at Highest Risk for Hypoglycemia?

The risk of hypoglycemia significantly increases when tirzepatide is taken concurrently with insulin secretagogues, such as sulfonylureas (e.g., glipizide, glyburide), or with insulin itself. This combination can lead to an excessive drop in blood glucose.

The FDA prescribing information for tirzepatide highlights this risk. In a clinical trial where tirzepatide was added to basal insulin, hypoglycemia (blood glucose <54 mg/dL) was reported in up to 19.3% of patients on the 15 mg dose.

In contrast, when used with metformin, the incidence of clinically significant hypoglycemia was much lower, reported at 1.7% for the 15 mg dose of tirzepatide in the SURPASS-2 trial. This underscores that the concurrent medications are the primary driver of risk.

Before starting tirzepatide, your physician will review your current medications. A reduction in the dose of your sulfonylurea or insulin may be necessary to mitigate the risk of severe low blood sugar events. You can find more information on medication safety on our main GOAL.MD Answers page.

Warning Signs and Symptoms of Low Blood Sugar

Recognizing the early signs of hypoglycemia is crucial for safe and prompt treatment. Mild to moderate symptoms often appear suddenly and can include shakiness, dizziness, sweating, anxiety, irritability, and a fast heartbeat (palpitations).

Other common symptoms include intense hunger, headache, blurred vision, and a pale complexion. These signs are your body's alarm system, indicating that your brain and muscles are not getting enough glucose for fuel.

If left untreated, hypoglycemia can worsen, leading to more severe symptoms. These include confusion, difficulty speaking, poor coordination, and unusual behavior. In the most severe cases, it can result in seizures, loss of consciousness, or coma.

How to Manage a Hypoglycemic Event

If you experience symptoms of low blood sugar, it's important to check your glucose level with a glucometer if possible. The American Diabetes Association defines clinically significant hypoglycemia as a blood glucose level of 54 mg/dL or lower.

For conscious individuals, the standard treatment is the "Rule of 15." Consume 15 grams of a fast-acting carbohydrate, such as 4 glucose tablets, 4 ounces of juice or regular soda, or 1 tablespoon of honey. Wait 15 minutes, then recheck your blood sugar.

If your blood sugar is still low after 15 minutes, repeat the process. Once your level has returned to a safe range (typically above 70 mg/dL), eat a small snack containing both carbohydrates and protein to prevent another drop.

For severe hypoglycemia where a person is unable to safely swallow, they will require assistance. A glucagon emergency kit, either as an injection or nasal spray, should be administered by another person, and 911 should be called immediately.

Bottom Line

While tirzepatide itself carries a low risk of causing hypoglycemia, this risk increases dramatically when combined with insulin or sulfonylurea medications. It is essential for patients to be aware of this interaction.

Working closely with a physician-supervised program is key to managing this risk. Your doctor may proactively adjust your other diabetes medications when starting or titrating your dose of tirzepatide.

Knowing the warning signs—from shakiness and sweating to confusion—and understanding how to treat a low blood sugar event with the "Rule of 15" are critical for your safety. Always discuss your specific risks and treatment plan with your healthcare provider.

This article is for informational purposes only and does not constitute medical advice.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.